CPRX (STOCKS)
Catalyst Pharmaceutical Inc.
$24.950000
+0.010000 (+0.04%)
Prev close: $24.940000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Richard John Daly
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,093.40M
- Employees
- 167
- P/E (TTM)
- 14.81
- P/B (TTM)
- 3.20
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $588.99M |
| Benefits Costs and Expenses | $305.47M |
| Cost Of Revenue | $87.25M |
| Costs And Expenses | $305.47M |
| Gross Profit | $501.74M |
| Operating Expenses | $206.46M |
| Selling, General, and Administrative Expenses | $193.75M |
| Research and Development | $12.71M |
| Operating Income/Loss | $257.78M |
| Income/Loss From Continuing Operations After Tax | $214.33M |
| Income/Loss From Continuing Operations Before Tax | $283.52M |
| Income Tax Expense/Benefit | $69.19M |
| Income Tax Expense/Benefit, Current | $75.95M |
| Income Tax Expense/Benefit, Deferred | -$6.77M |
| Net Income/Loss | $214.33M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $214.33M |
| Net Income/Loss Available To Common Stockholders, Basic | $214.33M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.75 |
| Diluted Earnings Per Share | $1.68 |
| Basic Average Shares | 122,290,866 |
| Diluted Average Shares | 127,257,929 |
| Assets | $1.10B |
| Current Assets | $894.03M |
| Inventory | $37.17M |
| Other Current Assets | $856.86M |
| Noncurrent Assets | $209.95M |
| Fixed Assets | $1.04M |
| Other Non-current Assets | $208.91M |
| Liabilities | $149.71M |
| Current Liabilities | $147.15M |
| Accounts Payable | $11.20M |
| Wages | $11.36M |
| Other Current Liabilities | $124.59M |
| Noncurrent Liabilities | $2.56M |
| Equity | $954.27M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $954.27M |
| Liabilities And Equity | $1.10B |
| Net Cash Flow From Operating Activities | $208.67M |
| Net Cash Flow From Operating Activities, Continuing | $208.67M |
| Net Cash Flow From Investing Activities | -$58.00K |
| Net Cash Flow From Investing Activities, Continuing | -$58.00K |
| Net Cash Flow From Financing Activities | -$16.99M |
| Net Cash Flow From Financing Activities, Continuing | -$16.99M |
| Net Cash Flow | $191.62M |
| Net Cash Flow, Continuing | $191.62M |
| Comprehensive Income/Loss | $214.26M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $214.26M |
| Other Comprehensive Income/Loss | -$64.00K |